Urinary tract infections (UTI) is the most common infection experienced by human after respiratory tract infection ([@B1]), accounting for 8.6 million visits (84% by women) in 2007 in the United States ([@B2]). Up to 60% of women have symptomatic UTIs during their lifespan, and 10% of women have UTIs annually. UTI in men is uncommon but often associated with structural abnormality ([@B3]). Although the most frequent etiology continues to be *Escherichia col*i (E.coli). Since the resistance patterns of E. coli strains causing UTI varies considerably between regions and countries, a specific treatment recommendation may not be universally suitable for all regions or countries ([@B4]). Active surveillance studies of in vitro susceptibility of uropathogens in women with uncomplicated cystitis are helpful in making decisions about empirical therapy ([@B4]). Evidence proves that antibiotic-resistance genes were present in the era before antibiotic therapy was available, and they probably originated from antibiotic-producing bacteria ([@B5], [@B6]).

At least eight distinctive mechanisms of antibiotic resistance have been described in bacteria ([@B7]). To avoid treatment failure, and bacterial resistance, it is necessary to be aware of local antibiotic resistance for selecting an appropriate antibiotic for empiric therapy. The aim of this study was to assess the resistance patterns of E.coli causing urinary tract infections to commonly used antimicrobials and to evaluate the options for empirical treatment of UTI in Babol, North of Iran.

Methods
=======

This cross- sectional study was conducted in Ayatollah Rouhani Teaching Hospital of Babol Medical Sciences University, North of Iran, during 2013. Urine was collected from 57 community patients who referred to the hospital laboratory of the hospital. All urine samples collected by midstream clean-catch or catheterization were obtained. These samples were processed on blood agar and EMB medium with a standard loop and were incubated at 37^o^c for 24 hours.

Urine specimen positive for E.coli \>~=~10^5^ cfu/ml referred to Department of Microbiology of Babol Medical School for confirmation and detection of susceptibility to antibiotics. Antibiotics susceptibility testing was performed by disk diffusion and microdilution method according to Clinical and Laboratory Standards Institute (CLSI) 2013 for ceftizoxime, cefotaxime, ceftriaxone, cefepime, cefexime, ciprofloxacin, ofloxacin, imipenem, cotrimoxazole and gentamicyn.

To determine the susceptibility of bacteria to antibiotic sensitivity tests, antibiogram method was implemented using the disc initially sterile swab impregnated with microbial suspension Mueller Hinton agar medium. Then, by using forceps, antibiotic disks at least 1cm of each other in medium was placed. For each period forceps should be sterilized with a flame. After the disks, plates were incubated for 24h at 37 ° C. After 24 hours, the diameter of the inhibition zone around the disk was measured using a ruler and with CLSI 2013 as a resistant, semi-sensitive or sensitive bacteria had been reported.

To determine the MIC of the antibiotic microdilution, broth method was used. To provide appropriate dose of antibiotics, 5,000 micrograms of antibiotics were mixed in 500 microliter water soluble and allocated in1 microliter microtubes and then put them in the freezer. In microdilution broth method, each microplate has 96-wells. It had 8 rows and 12 columns. (The number of rows A-H and columns 1-12 were numbered). Blank column No. 11 as a negative control and column No. 12 a positive control.

At first in all wells of column 1 and the first well of negative control, 200 microliter of medium BHI broth was added. Then in the other wells 100 μl BHI broth medium was added.

Then antibiotics were added in all wells of the first column and in the first well of negative control column. For the preparation of the antibiotic concentration ratio of ⅓, 100 ml of column 1 was transferred to column 2 and from column 2 to column 3 and to column 10 and 100 microliter remaining at the sampler top were discarded. Thus, the respective dose of antibiotics for columns 1 to 10 were prepared as follows: 128 μgr / ml ,64μ gr / ml, 32 μ gr / ml, 16 gr / ml, 8 μ gr / ml, 4 μ gr / ml , 2 μ gr / ml, 1 μ gr / ml, 0.5 μ gr / ml, 0. 25 μ gr / ml.

To prepare the appropriate concentration of antibiotics in negative control wells, 100 ml from well A transfered to well B and H, and the remaining 100 microliter at the tip of sampler was discarded. After bacteria were cultured on BHI medium, a half McFarland turbidity suspension was prepared.

The next phase of bacterial suspension was to create a dilution of 1/10 and then 5 microliter was added to all wells except the negative control well. Ultimately, the final volume of 100 ml was all wells. Negative control was free of bacteria and positive control was free of antibiotics. The microplate was incubated for 24 h and temperature was at 37°C.

After 24 hours, the microplate was examined under light of which the last staining was observed as the minimum inhibitory concentrations of antibiotics that considered avulsion compared with CLSI 2013 table as resistant, moderately susceptible and susceptible of bacteria to antibiotics was reported.

In this evaluation, ceftizoxime, cefotaxime, ceftriaxone, cefepime, cefexime, ciprofloxacin, ofloxacin, imipenem, Co-trimoxazole and gentamicyn were studied. All agents were from Merck and Co. (Germany).

Statical analysis was performed using the SPSS Version 17. The table ***making a CAT diagnosis*** was used to compare the disk diffusion with MIC, accumulation, positive predictive value, negative predictive value, sensitivity and specificity of disk diffusion.

Results
=======

In this study, we found that 57 E.coli isolated in our hospital were susceptible to imipenem, ofloxacin, ciprofloxacin with the following resistance of 87.7%, 87.7% and 78.9% respectively. Also, cotrimoxazole, cefexime, cefotaxime and ceftriaxone were the most resistant antibiotics ([table 1](#T1){ref-type="table"}). According to disk diffusion, ofloxacin, ciprofloxacin, and cefepime were the most sensitive antibiotics at 84.2%, 68.4% and 68.4%, respectively, whereas cotrimoxazole, ceftotaxime and ceftriaxone were the most resistant antibiotics ([table 2](#T2){ref-type="table"}).

Disk diffusion antibiotic sensitivity compared with MIC detection microdilution method had sensitivity, specificity, positive predictive value and negative predictive value of 82%, 98%, 99% and 74% respectively.

###### 

Antibiotics susceptibility of E.coli causing UTI by microdilution method

  **Antibiotics**   **sensitive**   **Intermediate**   **resistance**
  ----------------- --------------- ------------------ ----------------
  Ceftizoxime       66.7            7                  27.3
  Cefotaxime        56.1            8.8                35.1
  Ceftriaxone       57.9            7                  35.1
  Ciprofloxacin     78.9            7                  14
  Ofloxacin         87.7            5.3                7
  Imipenem          87.7            7                  5.3
  Co.trimoxazole    29.8            7                  63.2
  Cefepime          77.2            12.3               10.5
  Cefixime          61.4            3.5                35.1
  Gentamicin        63.2            12.3               24.6

###### 

Antibiotics susceptibility of E.coli causing UTI by disk diffusion

  **Antibiotics**   **sensitive**   **Intermediate**   **resistance**
  ----------------- --------------- ------------------ ----------------
  Ceftizoxime       56.1            3.5                40.4
  Cefotaxime        45.6            8.8                45.6
  Ceftriaxone       52.6            1.8                45.6
  Ciprofloxacin     68.4            7                  24.6
  Ofloxacin         84.2            7                  8.8
  Imipenem          56.1            5.3                38.6
  Co.trimoxazole    24.6            10.5               64.9
  Cefepime          68.4            8.8                22.8
  Cefixime          50.9            5.3                43.9
  Gentamicin        49.1            14                 36.8

Discussion
==========

In this study, we found that the most isolated E.coli were susceptible to imipenem, ofloxacin and ciprofloxacin. These two oral agents can be used for outpatient cases, but those who were hospitalized should be treated with imipenem as parenteral agent. Several studies performed in Iran and other country had findings similar to the results of our study ([@B8]-[@B13]), but in contrast, in Spain and Germany, the susceptibility to ciprofloxacin was more than 90% ([@B14], [@B15]). In other studies performed in developing countries showed lower sensitivity to ciprofloxacin between 15% to 43.2% ([@B16], [@B17]).

Another finding in our study was the high rate of resistance to cotrimoxazole as shown in other studies in other parts of Iran ([@B10], [@B11], [@B13], [@B18]) and Nigeria ([@B16]). But resistance to cotrimoxazole was low in Spain and Austria ([@B14], [@B19]). These differences may be due to the lower administration of this agent in these developed countries. Therefore, cotrimoxazole should not be used in developing countries as empirical therapy for UTI. In this study, we found moderate resistance to cefexime and other third generation cephalosporins as shown by other researchers in other cities in Iran ([@B10]-[@B13], [@B18], [@B20]). On the contrary, the resistance to cefotaxime and other third generation cephalosporins was low in Austria ([@B19]). These findings emphasize to delineate an algorithm to specify a treatment of patient in developed and developing countries. Another finding in our study was the similarity of the disk diffusion test and MIC for the detection of sensitivity of various antibiotics as investigated and approved by other researchers ([@B21]-[@B23]). The weakness of our study is the lack of information about the previous used antibiotic in our patients before entering in the study. In conclusion, our results showed that imipenem, ofloxacin and ciprofloxacin should be used in empirical therapy of UTI. Cotrimoxazole and third generation cephalosporins should not be used in empirical therapy of UTI especially pyelonephritis.
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